Use of IV Albumin in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis

This chapter provides a summary of a landmark study in gastroenterology. Does the administration of IV albumin improve survival in patients admitted to the hospital with cirrhosis and spontaneous bacterial peritonitis? Starting with that question, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.